Amphastar Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US03209R1032

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Yakob Liawatidewi. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Yakob Liawatidewi har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:AMPH / Amphastar Pharmaceuticals, Inc. EVP CORP ADMIN CENTER, Director 121.892
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Yakob Liawatidewi. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb AMPH / Amphastar Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AMPH / Amphastar Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AMPH / Amphastar Pharmaceuticals, Inc. Insider Trades
Insidersalg AMPH / Amphastar Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AMPH / Amphastar Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2021-05-17 AMPH Liawatidewi Yakob 9.637 19,9944 9.637 19,9944 192.686 116 17.83 -20.858 -10,83
2021-05-14 AMPH Liawatidewi Yakob 3.186 19,9164 3.186 19,9164 63.454
2021-05-12 AMPH Liawatidewi Yakob 4.592 19,3254 4.592 19,3254 88.742
2021-05-11 AMPH Liawatidewi Yakob 10.000 19,0597 10.000 19,0597 190.597
2020-06-09 AMPH Liawatidewi Yakob 23.405 20,4060 23.405 20,4060 477.602
2019-09-13 AMPH Liawatidewi Yakob 3.000 21,4467 3.000 21,4467 64.340
2019-09-06 AMPH Liawatidewi Yakob 2.395 21,9018 2.395 21,9018 52.455
2019-09-05 AMPH Liawatidewi Yakob 1.515 21,2433 1.515 21,2433 32.184
2018-11-30 AMPH Liawatidewi Yakob 11.500 21,4995 11.500 21,4995 247.244
2018-11-30 AMPH Liawatidewi Yakob 2.480 21,4795 2.480 21,4795 53.269
2018-11-28 AMPH Liawatidewi Yakob 1.520 20,4870 1.520 20,4870 31.140
2018-11-23 AMPH Liawatidewi Yakob 1.299 20,2577 1.299 20,2577 26.315

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AMPH / Amphastar Pharmaceuticals, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Yakob Liawatidewi som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2026-03-17 2026-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.033 121.892 -0,84 18,18 -18.780 2.215.997
2026-03-11 2026-03-10 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.870 122.925 -1,50 18,91 -35.362 2.324.512
2026-03-11 2026-03-09 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 35.450 124.795 39,68
2026-03-10 2026-03-06 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.144 89.345 -1,26 19,34 -22.125 1.727.932
2026-03-06 2026-03-04 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -965 90.489 -1,06 19,96 -19.261 1.806.160
2025-03-18 2025-03-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.731 90.909 -1,87 27,69 -47.931 2.517.270
2025-03-18 2025-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.031 92.640 -1,10 26,66 -27.486 2.469.782
2025-03-12 2025-03-10 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 20.837 93.671 28,61
2025-03-10 2025-03-06 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.141 72.834 -1,54 28,32 -32.313 2.062.659
2025-03-06 2025-03-04 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -963 73.975 -1,29 27,62 -26.598 2.043.190
2024-11-08 2024-11-06 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -5.214 74.938 -6,51 52,05 -271.389 3.900.523
2024-11-08 2024-11-06 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 5.214 80.152 6,96 13,03 67.938 1.044.381
2024-06-05 2024-06-04 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -272 74.938 -0,36 42,22 -11.484 3.163.882
2024-03-19 2024-03-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.726 74.778 -2,26 43,05 -74.304 3.219.193
2024-03-19 2024-03-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.671 76.504 -2,14 43,05 -71.937 3.293.497
2024-03-19 2024-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.027 78.175 -1,30 43,05 -44.212 3.365.434
2024-03-08 2024-03-06 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.221 79.202 -1,52 46,31 -56.545 3.667.845
2024-03-06 2024-03-04 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 10.754 80.423 15,44
2023-08-29 2023-08-28 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -28.816 69.669 -29,26 53,13 -1.530.994 3.701.514
2023-08-29 2023-08-28 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 20.000 98.485 25,48 13,03 260.600 1.283.260
2023-08-29 2023-08-28 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 5.497 78.485 7,53 20,23 111.204 1.587.752
2023-08-29 2023-08-28 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 3.319 72.988 4,76 16,96 56.290 1.237.876
2023-06-06 2023-06-04 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -378 69.669 -0,54 46,70 -17.653 3.253.542
2023-04-14 2023-04-13 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -6.494 69.215 -8,58 42,00 -272.748 2.907.030
2023-04-14 2023-04-13 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -5.000 75.709 -6,20 41,00 -205.000 3.104.069
2023-04-14 2023-04-13 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 11.494 80.709 16,61 20,23 232.524 1.632.743
2023-04-12 2023-04-10 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -5.000 69.215 -6,74 40,00 -200.000 2.768.600
2023-04-12 2023-04-10 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 5.000 74.215 7,22 20,23 101.150 1.501.369
2023-03-20 2023-03-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.673 69.215 -2,36 36,29 -60.713 2.511.812
2023-03-20 2023-03-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.620 70.888 -2,23 37,60 -60.912 2.665.389
2023-03-17 2023-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.851 72.508 -2,49 36,84 -68.191 2.671.195
2023-03-08 2023-03-06 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 12.752 74.359 20,70
2022-08-10 2022-08-09 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -3.055 61.607 -4,72 39,00 -119.145 2.402.673
2022-08-10 2022-08-09 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 3.055 64.662 4,96 19,79 60.458 1.279.661
2022-08-10 2022-08-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -5.000 61.607 -7,51 38,00 -190.000 2.341.066
2022-08-10 2022-08-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 5.000 66.607 8,12 19,79 98.950 1.318.153
2022-07-18 2022-07-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -7.359 61.607 -10,67 36,97 -272.086 2.277.808
2022-07-18 2022-07-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -3.478 68.966 -4,80 35,94 -124.997 2.478.597
2022-07-18 2022-07-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 10.837 72.444 17,59 19,79 214.464 1.433.667
2022-06-15 2022-06-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -128 61.607 -0,21 31,02 -3.971 1.911.049
2022-06-06 2022-06-04 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -264 61.735 -0,43 37,77 -9.971 2.331.731
2022-03-18 2022-03-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.673 60.740 -2,68 34,18 -57.183 2.076.093
2022-03-18 2022-03-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.619 62.413 -2,53 34,22 -55.402 2.135.773
2022-03-17 2022-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
A - Award 26.567 26.567
2022-03-17 2022-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.559 64.032 -2,38 34,74 -54.160 2.224.472
2022-03-17 2022-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 11.514 65.591 21,29
2021-08-03 2021-08-02 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -8.932 0 -100,00
2021-08-03 2021-08-02 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -8.932 54.077 -14,18 21,14 -188.805 1.143.080
2021-08-03 2021-08-02 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 8.932 63.009 16,52 14,95 133.533 941.985
2021-07-16 2021-07-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -7.674 36.176 -17,50
2021-07-16 2021-07-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -23.352 0 -100,00
2021-07-16 2021-07-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -31.524 54.077 -36,83 20,01 -630.688 1.081.897
2021-07-16 2021-07-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 7.674 85.601 9,85 13,03 99.992 1.115.381
2021-07-16 2021-07-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 23.352 77.927 42,79 13,35 311.749 1.040.325
2021-06-15 2021-06-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -128 54.575 -0,23 19,68 -2.519 1.074.036
2021-06-08 2021-06-04 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -264 54.703 -0,48 18,79 -4.961 1.027.869
2021-05-18 2021-05-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Empoyee Stock Option (right to buy)
M - Exercise -9.637 0 -100,00
2021-05-18 2021-05-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -9.637 53.573 -15,25 19,99 -192.686 1.071.160
2021-05-18 2021-05-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 9.637 63.210 17,99 11,33 109.187 716.169
2021-05-18 2021-05-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -3.186 53.573 -5,61 19,92 -63.454 1.066.981
2021-05-13 2021-05-12 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -4.592 56.759 -7,48 19,33 -88.742 1.096.890
2021-05-13 2021-05-11 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -10.000 9.637 -50,92
2021-05-13 2021-05-11 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -10.000 61.351 -14,02 19,06 -190.597 1.169.332
2021-05-13 2021-05-11 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 10.000 71.351 16,30 11,33 113.300 808.407
2021-03-18 2021-03-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
A - Award 45.420 45.420
2021-03-18 2021-03-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 19.344 61.351 46,05
2021-03-18 2021-03-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -2.430 42.007 -5,47 18,44 -44.809 774.609
2021-03-17 2021-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.559 44.437 -3,39 19,15 -29.855 850.969
2020-07-22 2020-07-21 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -5.978 19.637 -23,34
2020-07-22 2020-07-21 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -5.978 45.996 -11,50 21,22 -126.837 975.911
2020-07-22 2020-07-21 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 5.978 51.974 13,00 11,33 67.731 588.865
2020-07-22 2020-07-20 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -4.186 25.615 -14,05
2020-07-22 2020-07-20 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -4.186 45.996 -8,34 21,03 -88.047 967.461
2020-07-22 2020-07-20 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 4.186 50.182 9,10 11,33 47.427 568.562
2020-06-15 2020-06-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -128 45.996 -0,28 19,58 -2.506 900.602
2020-06-10 2020-06-09 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -16.000 16.000 -50,00
2020-06-10 2020-06-09 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -23.405 46.124 -33,66 20,41 -477.602 941.206
2020-06-10 2020-06-09 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 16.000 69.529 29,89 10,93 174.880 759.952
2020-06-08 2020-06-04 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
A - Award 7.091 7.091
2020-06-08 2020-06-04 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 3.048 53.529 6,04
2020-03-18 2020-03-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -859 49.168 -1,72 14,50 -12.456 712.936
2020-03-18 2020-03-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
A - Award 43.850 43.850
2020-03-18 2020-03-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 18.726 50.027 59,83
2020-03-18 2020-03-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -810 31.301 -2,52 13,03 -10.554 407.852
2020-03-17 2020-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.559 32.111 -4,63 14,19 -22.122 455.655
2019-09-17 2019-09-13 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -3.000 33.670 -8,18 21,45 -64.340 722.110
2019-09-09 2019-09-06 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -2.395 2.459 -49,34 21,90 -52.455 53.857
2019-09-09 2019-09-05 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -1.515 4.854 -23,79 21,24 -32.184 103.115
2019-08-14 2019-08-13 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -5.000 16.000 -23,81
2019-08-14 2019-08-13 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -5.000 36.670 -12,00 20,73 -103.653 760.191
2019-08-14 2019-08-13 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 5.000 41.670 13,64 10,93 54.650 455.453
2019-08-14 2019-08-12 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -5.000 21.000 -19,23
2019-08-14 2019-08-12 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -10.518 36.670 -22,29 20,44 -214.962 749.443
2019-08-14 2019-08-12 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 5.000 47.188 11,85 10,93 54.650 515.765
2019-06-17 2019-06-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -195 42.188 -0,46 19,82 -3.865 836.166
2019-03-27 2019-03-26 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -885 41.273 -2,10 20,54 -18.178 847.747
2019-03-19 2019-03-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.307 42.158 -3,01 20,23 -26.441 852.856
2019-03-19 2019-03-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.233 43.465 -2,76 20,23 -24.944 879.297
2019-03-19 2019-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
A - Award 21.991 21.991
2019-03-19 2019-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.071 44.698 -2,34 20,23 -21.666 904.241
2019-03-19 2019-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 9.886 45.769 27,55
2019-02-14 2019-02-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -4.868 8.932 -35,28
2019-02-14 2019-02-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -4.868 35.883 -11,95 24,00 -116.832 861.192
2019-02-14 2019-02-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 4.868 40.751 13,57 14,95 72.777 609.227
2019-02-14 2019-02-12 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -4.000 13.800 -22,47
2019-02-14 2019-02-12 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -4.000 35.883 -10,03 23,70 -94.800 850.427
2019-02-14 2019-02-12 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 4.000 39.883 11,15 14,95 59.800 596.251
2019-02-06 2019-02-05 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -9.817 0 -100,00
2019-02-06 2019-02-05 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -11.397 35.883 -24,11 23,18 -264.167 831.718
2019-02-06 2019-02-05 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 9.817 47.280 26,20 10,48 102.882 495.494
2019-01-24 2019-01-23 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -4.000 9.817 -28,95
2019-01-24 2019-01-23 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -4.000 37.463 -9,65 22,65 -90.600 848.537
2019-01-24 2019-01-23 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 4.000 41.463 10,68 10,48 41.920 434.532
2019-01-24 2019-01-22 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -3.000 13.817 -17,84
2019-01-24 2019-01-22 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -3.000 37.463 -7,41 22,35 -67.050 837.298
2019-01-24 2019-01-22 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 3.000 40.463 8,01 10,48 31.440 424.052
2019-01-16 2019-01-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
M - Exercise -3.175 16.817 -15,88
2019-01-16 2019-01-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -3.175 37.463 -7,81 22,15 -70.326 829.805
2019-01-16 2019-01-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 3.175 40.638 8,48 10,48 33.274 425.886
2019-01-16 2019-01-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
M - Exercise -8 19.992 -0,04
2019-01-16 2019-01-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -8 37.463 -0,02 22,15 -177 829.805
2019-01-16 2019-01-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 8 37.471 0,02 10,48 84 392.696
2018-12-03 2018-11-30 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise -11.500 0 -100,00
2018-12-03 2018-11-30 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -2.480 6.369 -28,03 21,48 -53.269 136.803
2018-12-03 2018-11-30 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -11.500 37.463 -23,49 21,50 -247.244 805.436
2018-12-03 2018-11-30 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 11.500 48.963 30,70 20,26 232.990 991.990
2018-11-29 2018-11-28 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -1.520 8.849 -14,66 20,49 -31.140 181.289
2018-11-26 2018-11-23 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -1.299 37.463 -3,35 20,26 -26.315 758.914
2018-11-13 2018-11-09 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
M - Exercise -4.904 0 -100,00
2018-11-13 2018-11-09 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
M - Exercise -4.903 0 -100,00
2018-11-13 2018-11-09 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -11.808 38.762 -23,35 21,21 -250.421 822.053
2018-11-13 2018-11-09 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 4.904 50.570 10,74 14,40 70.618 728.208
2018-11-13 2018-11-09 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 4.903 45.666 12,03 14,23 69.770 649.827
2018-11-13 2018-11-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
M - Exercise -6.000 0 -100,00
2018-11-13 2018-11-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -6.000 40.763 -12,83 20,50 -123.000 835.642
2018-11-13 2018-11-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 6.000 46.763 14,72 11,41 68.460 533.566
2018-06-18 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
88.947
2018-06-18 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
60.027
2018-06-18 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
88.947
2018-06-18 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
60.027
2018-06-18 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
88.947
2018-06-18 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
60.027
2018-06-18 2018-06-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 3.319 3.319
2018-06-18 2018-06-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 1.474 40.763 3,75
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)